{"id":"NCT00463047","sponsor":"Cephalon","briefTitle":"Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain","officialTitle":"A Randomized, Double-Blind, Active-Controlled Crossover Study to Evaluate the Efficacy and Safety of Fentanyl Buccal Tablets Compared With Immediate-release Oxycodone for the Management of Breakthrough Pain in Opioid-Tolerant Patient With Chronic Pain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-07","primaryCompletion":"2009-02","completion":"2009-02","firstPosted":"2007-04-19","resultsPosted":"2010-12-14","lastUpdate":"2012-05-28"},"enrollment":323,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Pain"],"interventions":[{"type":"DRUG","name":"Fentanyl Buccal Tablets Compared With Immediate-Release Oxycodone","otherNames":[]}],"arms":[{"label":"Fentanyl Buccal Tablets (FBT)","type":"EXPERIMENTAL"},{"label":"Oxycodone","type":"ACTIVE_COMPARATOR"}],"summary":"Evaluate the efficacy of treatment with Fentanyl Buccal Tablets (FBT) compared with immediate release oxycodone in alleviating breakthrough pain in opioid tolerant patients with chronic pain.","primaryOutcome":{"measure":"Pain Intensity Difference (PID15) At 15 Minutes","timeFrame":"Immediately pre-dose and fifteen minutes after administration of study drug","effectByArm":[{"arm":"Fentanyl Buccal Tablets (FBT)","deltaMin":0.82,"sd":0.07},{"arm":"Immediate-Release Oxycodone","deltaMin":0.59,"sd":0.07}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":10,"exclusionCount":15},"locations":{"siteCount":45,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":281},"commonTop":["Nausea","Headache","Application site pain","Application site ulcer","Dizziness"]}}